CardioNet
Develops diagnostic and patient management tools for the diagnosis and treatment of patients with cardiovascular disease.
Launch date
Employees
Market cap
-
Enterprise valuation
€400—600m (Dealroom.co estimates Mar 2007.)
Conshohocken Pennsylvania (HQ)
Financials
Estimates*
| CAD | 2019 | 2020 |
|---|---|---|
| Revenues | 5.0m | 47.0m |
| % growth | - | 840 % |
| EBITDA | (10.0m) | 4.0m |
| % EBITDA margin | (200 %) | 9 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
$6.9m | Series B | ||
$13.0m | Series C | ||
$10.0m Valuation: $230m | Series D | ||
| N/A | $110m | Series E | |
| N/A | $81.0m | IPO | |
| Total Funding | €127m | ||
Recent News about CardioNet
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by CardioNet
Edit
ACQUISITION by CardioNet Aug 2012
ACQUISITION by CardioNet Feb 2012